Laserfiche WebLink
<br />J-4 <br /> <br /> <br />Schedule B <br />Approved Uses <br />Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder <br />or Mental Health (SUD/MH) conditions through evidence-based or evidence-informed programs <br />or strategies that may include, but are not limited to, the following: <br />PART ONE: TREATMENT <br /> <br />A. TREAT OPIOID USE DISORDER (OUD) <br />Support treatment of Opioid Use Disorder (“OUD”) and any co-occurring Substance Use <br />Disorder or Mental Health (“SUD/MH”) conditions through evidence-based or evidence- <br />informed programs or strategies that may include, but are not limited to, those that:2 <br />1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, <br />including all forms of Medication-Assisted Treatment (“MAT”) approved by the U.S. <br />Food and Drug Administration. <br />2. Support and reimburse evidence-based services that adhere to the American Society <br />of Addiction Medicine (“ASAM”) continuum of care for OUD and any co-occurring <br />SUD/MH conditions. <br />3. Expand telehealth to increase access to treatment for OUD and any co-occurring <br />SUD/MH conditions, including MAT, as well as counseling, psychiatric support, and <br />other treatment and recovery support services. <br />4. Improve oversight of Opioid Treatment Programs (“OTPs”) to assure evidence-based <br />or evidence-informed practices such as adequate methadone dosing and low threshold <br />approaches to treatment. <br />5. Support mobile intervention, treatment, and recovery services, offered by qualified <br />professionals and service providers, such as peer recovery coaches, for persons with <br />OUD and any co-occurring SUD/MH conditions and for persons who have <br />experienced an opioid overdose. <br />6. Provide treatment of trauma for individuals with OUD (e.g., violence, sexual assault, <br />human trafficking, or adverse childhood experiences) and family members (e.g., <br />surviving family members after an overdose or overdose fatality), and training of <br />health care personnel to identify and address such trauma. <br />7. Support evidence-based withdrawal management services for people with OUD and <br />any co-occurring mental health conditions. <br /> <br />2 As used in this Schedule B, words like “expand,” “fund,” “provide” or the like shall not indicate a preference for <br />new or existing programs.